Jenburkt Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Name: Jenburkt Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Jenburkt Pharmaceuticals Ltd.
Rating: 2.788625
Author: Trendlyne DVM scores

Mid-range Performer

about

Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products. (Source : 202503 Annual Report Page No: 57)

1095.00 5.00 (0.46%)

550

BSE Volume

BSE 29 Aug, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

High Financial Strength

65.0 / 100

Mid Valuation

48.0 / 100

Technically Neutral

45.1 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

No estimates available

Jenburkt Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Jenburkt Pharmaceuticals Ltd. worth buying?

27 Votes:

Buy 62.96%

Sell 22.22%

Hold 14.81%

Jenburkt Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products. (Source : 202503 Annual Report Page No: 57)

SWOT Analysis

Jenburkt Pharma Live Price Chart